Tirzepatide 100mg
$150.00
RESEARCH USE ONLY
Out of stock
Description
Tirzepatide Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist that has become one of the most extensively studied incretin-based compounds for blood-glucose control and weight management.
Note: Tirzepatide is sometimes incorrectly marketed as “GLP-1.2.” Its established pharmacology is GIP/GLP-1 receptor agonism.
Product Information
Tirzepatide activates both GIP and GLP-1 receptors. These pathways influence glucose-dependent insulin secretion, appetite signaling, gastric emptying, and energy balance.
Large clinical trials have demonstrated substantial body-weight reduction and improvements in glycemic measures.
How Does Tirzepatide Work?
Tirzepatide activates GIP and GLP-1 receptors, influencing glucose regulation, appetite, and energy balance.
Tirzepatide Benefits & Effects
Promotes Weight Reduction
Clinical trials have demonstrated substantial reductions in body weight with Tirzepatide compared with placebo.
Improves Blood-Glucose Control
Tirzepatide improves glucose-dependent insulin secretion and has demonstrated significant reductions in HbA1c.
Reduces Appetite
GIP and GLP-1 signaling influences satiety and food intake, contributing to reduced appetite.
Supports Metabolic Research
Tirzepatide is extensively studied in obesity, type 2 diabetes, and broader metabolic research.
